Neonc Technologies (NASDAQ:NTHI) Trading Up 1.7% – Here’s What Happened

Shares of Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) were up 1.7% during trading on Friday . The stock traded as high as $10.18 and last traded at $10.00. Approximately 71,158 shares were traded during trading, an increase of 4% from the average daily volume of 68,476 shares. The stock had previously closed at $9.83.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Neonc Technologies in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Neonc Technologies Stock Performance

The business’s 50-day moving average is $8.85 and its 200 day moving average is $7.93.

Neonc Technologies (NASDAQ:NTHI) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.45) earnings per share (EPS) for the quarter.

Insider Transactions at Neonc Technologies

In related news, President Amir F. Heshmatpour acquired 6,000 shares of the stock in a transaction on Monday, November 24th. The shares were purchased at an average price of $6.51 per share, for a total transaction of $39,060.00. Following the purchase, the president directly owned 2,992,000 shares in the company, valued at approximately $19,477,920. The trade was a 0.20% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders purchased a total of 31,100 shares of company stock worth $192,099 over the last 90 days.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in NTHI. Foundations Investment Advisors LLC bought a new stake in Neonc Technologies during the third quarter worth $100,000. SLT Holdings LLC bought a new stake in shares of Neonc Technologies during the 3rd quarter worth $100,000. HCR Wealth Advisors acquired a new stake in Neonc Technologies in the second quarter valued at about $54,000. Royal Bank of Canada bought a new position in Neonc Technologies in the first quarter valued at about $247,000. Finally, LVW Advisors LLC bought a new position in Neonc Technologies in the second quarter valued at about $108,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.